Skip to main content

Table 1 Patient characteristics of biomarker discovery HF patient cohort

From: Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failure

Characteristics

HF hospitalisation or death (n = 50)

No event (n = 50)

p value

Age (years)

76.64 ± 8.14

76.64 ± 8.14

1.000

Male sex, n (%)

25 (50)

25 (50)

1.000

BMI (kg/m2)

30.01 ± 6.17

28.94 ± 6.66

0.471

NYHA class III/IV, n (%)

38 (76)

27 (54)

0.021

Systolic blood pressure (mmHg)

126.38 ± 20.63

130.94 ± 21.12

0.247

Diastolic blood pressure (mmHg)

66.92 ± 11.92

69.22 ± 12.24

0.324

Heart rate (bpm)

75.69 ± 19.91

73.94 ± 18.28

0.848

HF hospitalisation/Death

32/18

0/0

 

Serum creatinine (µmol/L)

126.88 ± 58.56

107.16 ± 34.27

0.076

eGFR (mL/min−1)

45.76 ± 14.23

51.34 ± 11.19

0.037

Primary aetiology

   

 Ischemic heart disease

40 (80)

32 (64)

0.118

 Non ischemic heart disease

10 (20)

18 (36)

0.118

  1. Italic values indicate significance of p value (p < 0.05)
  2. BMI body mass index, eGFR estimated glomerular filtration rate, NYHA New York Heart Association